Skip to main content
Thorax logoLink to Thorax
. 1967 Nov;22(6):519–524. doi: 10.1136/thx.22.6.519

Prolonged treatment of pulmonary sarcoidosis with corticosteroids

Clifford Hoyle 1, Hugh Smyllie 1,1, David Leak 1
PMCID: PMC471701  PMID: 6076506

Abstract

The results are described of prolonged corticosteroid treatment in 52 patients with pulmonary sarcoidosis observed for a mean duration of 10·5 years from diagnosis. Twenty of the patients were treated for less than one year, the remainder for a mean of five years. The mean length of observation after discontinuing treatment was 5·5 years. Selection of patients for treatment was based on (1) evidence from radiographic observation, even for two years or more, that the disease was progressive so that spontaneous remission was improbable; and (2) evidence of disturbed lung function, especially the onset of dyspnoea or an impaired diffusing capacity. Treatment, conveniently with prednisone at a maintenance dose of about 15 mg. daily, should be continued for at least a year and often for much longer until withdrawal is not followed by radiographic relapse. Such treatment does not increase the chance of a complete remission even when given at an early stage of the disease; and relief of dyspnoea is unpredictable and seldom considerable. But prolonged treatment will halt progressive lung destruction and appears to curb the eventual mortality.

Full text

PDF
524

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. HAMER N. A. CHANGES IN THE COMPONENTS OF THE DIFFUSING CAPACITY IN PULMONARY SARCOIDOSIS. Thorax. 1963 Sep;18:275–287. doi: 10.1136/thx.18.3.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. HOYLE C., DAWSON J., MATHER G. Treatment of pulmonary sarcoidosis with streptomycin and cortisone. Lancet. 1955 Mar 26;268(6865):638–643. doi: 10.1016/s0140-6736(55)90316-0. [DOI] [PubMed] [Google Scholar]
  3. HOYLE C. Prognosis of pulmonary sarcoidosis. Lancet. 1961 Sep 16;2(7203):611–615. doi: 10.1016/s0140-6736(61)90303-8. [DOI] [PubMed] [Google Scholar]
  4. MARSHALL R., SMELLIE H., BAYLIS J. H., HOYLE C., BATES D. V. Pulmonary function in sarcoidosis. Thorax. 1958 Mar;13(1):48–58. doi: 10.1136/thx.13.1.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. SCADDING J. G. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J. 1961 Nov 4;2(5261):1165–1172. doi: 10.1136/bmj.2.5261.1165. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES